Nanome Webinar Series

Stay tuned for future events!

Past Webinars

sam4_small copy

Sam Hessenauer

CTO & Co-Founder at Nanome
mike bishop

Michael Bishop, PhD

Drug Discovery Consultant at Nanome
chido

Chido Mpamhanga, PhD

Applied Computational Chemistry Domain Expert at Nanome

Amplifying the Human Element for AI in Drug Discovery: Introducing MARA by Nanome

Recorded November 15th, 2023

Using LLM technologies to amplify informatics and data-driven decision making within drug discovery.

Introduction of MARA, our new AI product purpose-built to be enterprise-ready, human centric, and collaborative

View on Demand
Jonathon Gast_sq (1)

Jonathon Gast, PhD

Senior Application Scientist at Nanome
Steve-079-edited

Steve McCloskey

CEO at Nanome

PROTACs in Mixed Reality: exploring protein interfaces and poses using the Data Table Plugin

Recorded June 29th, 2023

We showcase the Data Table plugin and demonstrate how to effectively use it when iterating on docking poses and exploring protein interfaces.

Learn how to use the Data Table plugin, designed for scientists working with multi-frame data and set to help the decision-making progress every time you are dealing with structures and data in Nanome. 

View on Demand
Jonathon Gast_sq (1)

Jonathon Gast, PhD

Senior Application Scientist at Nanome
Steve-079-edited

Steve McCloskey

CEO at Nanome

Revealing the new Nanome CryoEM plugin to target Prion Aggregates with Antibodies in XR

Recorded May 11th, 2023

We show how to smoothly navigate CryoEM maps in VR/MR, and provide insights on how this cutting-edge technology can help researchers better target prion aggregates with antibodies.

Learn how to visualize CryoEM maps in Nanome and how to leverage this plugin for your structural analysis. 

View on Demand
daniel gruffat

Daniel Gruffat, MS

Senior Application Scientist at Nanome
Steve-079-edited

Steve McCloskey

CEO at Nanome

Revolutionizing Cancer Treatment: A Live Stream on the Latest Approved Inhibitor for Gastric Cancer Kinase Structures in Mixed Reality

Recorded March 24th, 2023

Deep dive into the crystal structure of Tyrosine Kinase KIT1 in complex with DP2976, a close chloro analog of ripretinib, the latest approved inhibitor for gastrointestinal cancer. 

We provide a live examples of how multisite collaboration in Nanome and Mixed Reality looks like. 

View on Demand
roberta barlotta

Roberta Bartolotta, PhD

Application Scientist at Nanome
Steve-079-edited

Steve McCloskey

CEO at Nanome

Exploring the Crystal Structure of CRBN (Human Cereblon) Protein in Complex with Small Molecules for Drug Discovery Research:  a Live Stream in Nanome and Quest Pro’s Mixed Reality

Recorded February 24th, 2023

We analyzed the crystal structure of human Cereblon in complex with DDB1 and lenalidomide (PDBid 4tz4) LIVE!

We’ll be showcasing Meta’s newest headset, the Meta Quest Pro, and viewers will be able to experience the Passthrough Mixed Reality capabilities along with Nanome’s powerful scientific use cases.

View on Demand
Jonathon Gast_sq (1)

Jonathon Gast, PhD

Senior Application Scientist at Nanome
mike bishop

Mike Bishop, PhD

Drug Discovery Consultant at Nanome

Collaborative Drug Desing in XR

Recorded December 13th, 2022

How drug design and discovery can be improved across teams using XR. 

From pocket characterization to docking, and more, teams from all over the world can still come together in space through the power of XR tools

How does the day-to-day look like for scientists that use Nanome

View on Demand
harris headshot

Seth Harris, PhD

Director of Computational Structural Biology & Distinguished Scientist at Genentech

Exploring structural data landscapes for drug discovery:
GYST, a Genentech platform with Nanome XR integration

Recorded November 9th, 2022

Large-scale data extracts and annotations of structural features can accelerate drug discovery and research

Genentech's platform GYST creates datasets and enables their exploration by a broad range of researchers, while also provisioning information for machine learning models

Custom plugins enable seamless integration of Nanome as a visualization and analytical component in this system
radic_headshot-3

Zoran Radić, PhD

Adjunct Professor at UC San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences

Virtual Reality to Aid Antidote Design:
Structure-based design to treat organophosphate poisoning

Recorded June 22nd, 2022

  Understanding spatial impaction of Novichok-inhibited acetylcholinesterase is greatly facilitated by VR

3D structures of Acetylcholinesterase help explain its catalysis and provide a template for structure-based design while revealing an unexpected paradox

Structure-based analysis aided by VR accelerates the creation and refinement of antidotes against acetylcholinesterase poisoning
brian atwood - centered

Brian Atwood, PhD

Application Scientist at Iktos
rohit_arora

Rohit Arora, PhD

Application Scientist at Iktos

AI for the Science Metaverse:
how to accelerate drug discovery by using AI in VR

Recorded May 26th, 2022

  Iktos AI-technologies for generative chemistry and retrosynthesis planning

  Makya web application: AI for de novo drug design

Spaya web application: AI for discovering and prioritizing synthetic routes

Using Iktos tools in Nanome: a perfect place to collaborate
andrey

Andrey Kovalevsky, PhD

Senior R&D Scientist, Oak Ridge National Laboratory

Designing from "inside" the COVID-19 viral protein:
A novel chemical structure designed in VR

Recorded January 26th, 2022

Novel chemical structures for inhibiting SARS-CoV-2 replication

 VR-assisted structure-activity relationships

  Why Oak Ridge National Laboratory combines neutrons and VR for structure-based drug design

  How VR aids collaboration between structural biologists, medicinal chemists, and molecular modelers

A recording of this webinar is not available

Jackie von Salm is speaking at Nanome's next webinar

Jackie von Salm, PhD

Cofounder and CSO at Psilera Bioscience

Psychedelics & Virtual Reality: How VR aids GPCR drug discovery for a psychedelic biotech startup

Recorded Wednesday, November 17th, 2021

Why psychedelic research is so promising & what's on the horizon

Overcoming the challenges of communicating scientific research to investors

Easy ways to improve spatial awareness of chemists and the impact that brings to the lab

How Psilera is using Nanome to filter compounds

View on Demand
Wilian Cortopassi

Wilian Cortopassi

Senior Expert in Data Science at Novartis Institutes for BioMedical Research (NIBR)

The "Virtual" Reality of Drug Discovery at Novartis

Recorded Thursday, October 21st, 2021

  How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)

  A case study of the main protease (Mpro) of SARS-CoV-2

  Future outlook of VR at Novartis

A recording of this webinar is not available. Click below to download our case study with Novartis instead.

6abe93e5-a9d5-479a-8a9b-fb4c2da166ab_small

Woody Sherman

Chief Computational Scientist at Roivant Discovery, former CSO at Silicon Therapeutics

The Roivant Discovery vision for physics-driven drug design and the role of virtual reality to maximize insights.

Recorded Tuesday, August 24th, 2021

  What Roivant Discovery is doing with physics-driven drug design.

 The importance of structure-based drug discovery.

  Why VR is the next step to fully realize the benefit of structure-based drug discovery for visualization, collaboration, and design.

View on Demand